awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35132241-5F240D2C-A66D-4CB2-9070-FBD80CEFBE6F
Q35132241-5F240D2C-A66D-4CB2-9070-FBD80CEFBE6F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35132241-5F240D2C-A66D-4CB2-9070-FBD80CEFBE6F
Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies
P2860
Q35132241-5F240D2C-A66D-4CB2-9070-FBD80CEFBE6F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35132241-5F240D2C-A66D-4CB2-9070-FBD80CEFBE6F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6e495b8afe20f0567b5f681bc9f9062fa9c4c17f
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.